A recent Oncology Decoded podcast focuses on adjuvant therapy like pembrolizumab and optimal post-surgical care for patients with kidney cancer.
Benjamin Garmezy, MD
Advertisement
Articles by Benjamin Garmezy, MD
A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.
A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.
The Oncology Decoded podcast highlighted the impact of the results from the NIAGARA trial for patients with bladder cancer in a post-ASCO GU discussion.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel Vaccine Combo Shows Responses in Recurrent Epithelial Ovarian Cancer
2
FDA Accepts NDA for Gedatolisib in HR+/HER2–, PIK3CA Wild-Type Breast Cancer
3
Firmonertinib Demonstrates Promise in EGFR+ Advanced/Metastatic NSCLC
4
FDA Accepts NDA for Bezuclastinib Combo in Gastrointestinal Stromal Tumors
5